Loading people...
Cassie Doherty is an Investment Director at Northern Gritstone based in London and Cambridge, United Kingdom. She brings over two decades of venture experience bridging academic research and commercial innovation, having previously served as an investment professional at Parkwalk Advisors and Cambridge Enterprise. In her current capacity, she focuses on funding transformative life sciences companies, specifically targeting university spinouts operating within therapeutics, agricultural technology, and medical devices. Alongside her venture capital activities, she serves as a Trustee and the Chair of the Research and Innovation Committee for the Leeds Hospitals Charity. She holds a PhD in Biochemistry and Molecular Biology, with academic ties to both the University of Cambridge and the University of Leeds. Doherty primarily concentrates on commercializing early-stage scientific research by backing high-growth deep technology and healthcare ventures across the British academic ecosystem.
Cassie Doherty serves as a dedicated Investor at Parkwalk Advisors, a prominent EIS fund manager renowned for its focus on UK university spin-outs and deep tech companies. In this capacity, she plays a crucial role in the firm's investment process, from initial deal sourcing and rigorous due diligence to portfolio management and strategic support for investee companies. Her work directly contributes to Parkwalk's mission of bridging the gap between academic innovation and commercial success, helping to bring groundbreaking technologies and research to market.
Cassie's investment focus aligns closely with Parkwalk's core strategy, targeting early-stage, high-growth potential ventures originating from top UK universities. She is particularly interested in deep tech sectors, including artificial intelligence, advanced materials, engineering, software, and life sciences. Her expertise lies in identifying companies with strong intellectual property, scalable business models, and the potential for significant market disruption. She seeks out innovations that address critical challenges and offer substantial returns for investors.
While specific details of Cassie Doherty's career background are not extensively publicized, her role at Parkwalk Advisors suggests a strong foundation in venture capital, technology commercialization, or a related field. Investors at Parkwalk typically possess a blend of scientific or technical understanding, financial acumen, and experience in evaluating early-stage companies. This background enables them to effectively assess the complex technologies and market potential of university spin-outs, guiding them through critical growth phases. Her involvement underscores a commitment to fostering innovation within the UK's vibrant academic ecosystem.
As an investor within a fund structure like Parkwalk Advisors, Cassie Doherty contributes to a portfolio of diverse and impactful companies. While individual investors' specific deal lists are often internal, Parkwalk's overall portfolio includes numerous success stories across various deep tech domains. These investments typically involve companies that have successfully translated cutting-edge university research into viable commercial products or services, often attracting further funding rounds and achieving significant milestones. Cassie's work helps to identify and nurture these promising ventures, though specific public attribution for individual deals is less common for investors within a larger fund. Her efforts are integral to the collective success of Parkwalk's portfolio, supporting the next generation of UK innovators.
Cassie Doherty is an investor at Parkwalk Advisors, a leading EIS fund manager specializing in UK university spin-outs and deep tech companies. She focuses on identifying and supporting innovative early-stage ventures.
Cassie Doherty invests in high-growth potential companies emerging from UK universities, with a particular focus on deep tech sectors such as AI, advanced materials, engineering, software, and life sciences.
Cassie Doherty works as an Investor at Parkwalk Advisors, a prominent EIS fund manager based in the UK.
